QuickView for formate transmembrane transporter activity (biogroup)

1. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
2. Duodenum mucosa expression in MIII celiac disease patients
3. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
4. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
5. Idiopathic pulmonary fibrosis fibroblasts expression profiles

There were no matches for formate transmembrane transporter activity

1. Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
2. Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
3. Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
4. Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo
5. Sorafenib and TRC105 in Hepatocellular Cancer